Symrise Once Again Extends Contract Of CEO Heinz-Juergen Bertram

Symrise AG (SYIEY.PK,SYIEF.PK) said that its supervisory board once again extended the contract of Chief Executive Officer Heinz-Juergen Bertram ahead of schedule until 2025.

The company noted that Bertram will continue as CEO for a further three years and will drive forward the profitable growth course of the Group.

The company targets sales of 5.5 billion euros to 6 billion euros by 2025. Organic growth is expected to be between 5% and 7%. Symrise aims to generate an EBITDA margin in the range of 20% to 23%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT